drugset / Trial / NCT02096419
Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity
Phase 4
Completed
87 enrolled
University of Zagreb
Clinical Hospital Centre Zagreb · collabMinistry of Science, Education and Sport, Republic of Croatia · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether continuous clopidogrel dose adjustment targeted after platelet function testing improves outcomes during 12 months of follow-up in acute coronary syndrome patients treated with coronary artery stenting and with determined high platelet reactivity on clopidogrel.
Timeline
- Start
- 2012-02
- Primary completion
- 2013-12
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clopidogrel | Small molecule | 75 mg | — |
| Subject | Clopidogrel | Small molecule | 150 mg | — |
| Subject | Clopidogrel | Small molecule | 300 mg | — |